Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Unavailable04/24/19: FDA Blesses AbbVie's New Drug
Currently unavailable

04/24/19: FDA Blesses AbbVie's New Drug

FromCrain's Daily Gist


Currently unavailable

04/24/19: FDA Blesses AbbVie's New Drug

FromCrain's Daily Gist

ratings:
Length:
13 minutes
Released:
Apr 24, 2019
Format:
Podcast episode

Description

Today on Crain's Daily Gist, host Amy Guth talks with Crain's health care reporter Stephanie Goldberg about Chicago-based pharmaceutical company AbbVie and its new drug approved by the FDA. Plus: Boeing suspends its forecast on the grounding of the 737 Max, McDonald's turns up the pressure on Uber ahead of its IPO, Ford joins Amazon in investing in electric truck maker Rivian, Chicago's crypto industry takes a hit, and local entrepreneur Marc Bushala drops plans for a craft spirits business in the West Loop, planning to open event space instead. Follow host Amy Guth on Twitter @AmyGuth, and continue the conversation with #CrainsDailyGist.
Released:
Apr 24, 2019
Format:
Podcast episode

Titles in the series (100)

Get a head start on tomorrow during your commute home today. Listen to our roundup of essential Chicago headlines and analysis from Crain’s reporters and host Amy Guth. Presented by Wintrust.